Friday, 30 September 2022


GoBalto cloud-based trials software gets $12 mn

04 January 2013 | News | By BioSpectrum Bureau

Singapore's Economic Development Board invests $12 mn in cloud-based clinical trials software solutions' provider, GoBalto

Singapore's Economic Development Board invests $12 mn in cloud-based clinical trials software solutions' provider, GoBalto

Singapore: US-based GoBalto, which makes cloud-based software to support the clinical trials of pharmaceutical companies, raised funding worth $12 million in a Series B round from EDBI.

EDBI, which is the investing arm of Singapore's Economic Development Board, had recently been joined by Qualcomm Ventures; returning investors, Aberdare Ventures, and West Health Investment Fund.

GoBalto CEO, Mr Jae Chung, said that the company raised a total of $21 million from investors, and that its valuation is "in the tens-of-millions." Although GoBalto aims to create several products to simplify clinical-trials workflow, its first product is focused on the people that are hired by pharma firms to find human-trial subjects for drug studies. Mr Chung further revealed that said the country's five top pharma companies and five top contract research organizations (CROs) are users of their platform.

Sign up for the editor pick and get articles like this delivered right to your inbox.

Editors Pick
+Country Code-Phone Number(xxx-xxxxxxx)


Comments

× Your session has been expired. Please click here to Sign-in or Sign-up
   New User? Create Account